TECTONIC THERAPEUTIC, INC. Interest Expense, Other
TECTONIC THERAPEUTIC, INC. (TECX) reported Interest Expense, Other of $18.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-14.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpenseOther · last filed 2024-03-14
- TECTONIC THERAPEUTIC, INC. interest expense, other for the quarter ending 2023-12-31 was -$64.00K.
- TECTONIC THERAPEUTIC, INC. interest expense, other for the quarter ending 2023-09-30 was -$73.00K.
- TECTONIC THERAPEUTIC, INC. interest expense, other for the quarter ending 2023-06-30 was -$98.00K.
- TECTONIC THERAPEUTIC, INC. interest expense, other for the quarter ending 2023-03-31 was $253.00K.
- TECTONIC THERAPEUTIC, INC. interest expense, other for fiscal 2023 was $18.00K, a 66.04% decline from fiscal 2022.
- TECTONIC THERAPEUTIC, INC. interest expense, other for fiscal 2022 was $53.00K.
| Period end | Interest Expense, Other 3 month | Interest Expense, Other 6 month | Interest Expense, Other 9 month | Interest Expense, Other 12 month |
|---|---|---|---|---|
| 2023-12-31 | -$64.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | -$137.00K derived: sum of 2 quarters · filed 2024-03-14 | -$235.00K derived: sum of 3 quarters · filed 2024-03-14 | $18.00K 10-K · filed 2024-03-14 |
| 2023-09-30 | -$73.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$171.00K derived: sum of 2 quarters · filed 2023-11-09 | $82.00K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | -$98.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $155.00K 10-Q · filed 2023-08-10 | ||
| 2023-03-31 | $253.00K 10-Q · filed 2023-05-11 | |||
| 2022-12-31 | $53.00K 10-K · filed 2023-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |